Treatment
Growth Hormone clinical trials
We’re tracking 53 recruiting studies that include Growth Hormone, each written for real people, not researchers, below.
Recruiting studies
- NCT06103513RecruitingPhase 3
Comparing two starting doses of growth hormone in children
This study compares two different starting doses of growth hormone to see which works better for children who need it. It may help your child grow taller if they have growth hormone deficiency or short stature.
New York, New YorkAges 5–15 - NCT07553351RecruitingPhase 3
Growth hormone treatment for children with growth hormone deficiency
This trial tests a new growth hormone medicine (GB06) for children whose bodies don't make enough growth hormone naturally. The study will see if this treatment helps children grow taller over time.
Chengdu, SichuanAges 3–11 - NCT07333521Recruiting
Body composition in kids on growth hormone
This study looks at how growth hormone treatment affects body composition (fat and muscle) in children with growth hormone deficiency. It may help doctors better understand and monitor treatment effects.
ParisAges 3–17 - NCT07016802RecruitingPhase 1
Study of GenSci134 for growth hormone deficiency
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
Beijing, Beijing MunicipalityAges 18–70 - NCT05681299RecruitingPhase 4
Testing growth hormone and liraglutide effects on hunger hormones
This study tests how growth hormone (GH) and liraglutide affect a hunger-related hormone system called AgRP. It compares effects in healthy people (lean or overweight) and in people with isolated GH deficiency, aiming to understand how these treatments change appetite and metabolism.
New York, New YorkAges 18–45 - NCT05355272RecruitingPhase 2
Growth hormone treatment for Gulf War illness with low growth hormone
This Phase 2 study tests whether replacing growth hormone can improve symptoms in veterans with Gulf War Illness and adult growth hormone deficiency. It also checks that the treatment is safe for people with stable medications and hormone regimens.
Houston, TexasAges 18–64 - NCT00227253Recruiting
Study center for people with Chromosome 18
This trial is for people with Chromosome 18 (or the parent/guardian of a child with it) to take part in medical checkups and study evaluations. It may help researchers learn more about the condition and how to best evaluate patients safely.
San Antonio, TexasAges Any age - NCT04867317RecruitingPhase 3
Growth hormone treatment for veterans with mild traumatic brain injury and hormone deficiency
This study tests whether giving growth hormone, a natural substance that helps the body grow and repair tissues, can improve symptoms in veterans who have both a mild traumatic brain injury (concussion) and a deficiency in growth hormone. If you qualify, you may receive the treatment or a placebo (inactive shot), and the study will track your quality of life and symptoms over time.
Birmingham, AlabamaAges 21–55 - NCT06110910Recruiting
Growth hormone study for children with short stature
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
Wuhan, HubeiAges 2 years+ - NCT06948214RecruitingPhase 3
LUM-201 for growth hormone deficiency in children
This trial tests a new medicine called LUM-201 for children who haven't grown enough because their bodies don't make enough growth hormone. It aims to help kids who haven't been treated before and are still at an early stage of puberty.
Birmingham, AlabamaAges 3–11 - NCT06037473Recruiting
PEG growth hormone for short stature in children
This trial tests if a long-acting growth hormone (PEGylated GH) helps children with various causes of short stature grow taller. It may be an option if your child has a condition like growth hormone deficiency, Turner syndrome, or idiopathic short stature.
Beijing, Beijing MunicipalityAges Up to 18 years - NCT07551804RecruitingPhase 2
Growth hormone replacement therapy safety and effectiveness study
This study tests a new injectable growth hormone treatment for adults whose bodies don't produce enough growth hormone naturally. Researchers will measure how safe it is, how your body processes it, and whether it helps you feel better and function more normally.
BeijingAges 18–80 - NCT05447208RecruitingPhase 3
Testing growth hormone to improve embryo chromosome screening results
This Phase 3 study tests whether growth hormone given during IVF can improve the chance of getting embryos with the “right” number of chromosomes, which is checked by PGT-A. It may help some people who are 38 or older planning chromosome testing of embryos.
Shanghai, Shanghai MunicipalityAges 38 years+ - NCT06694506Recruiting
Health outcomes in adults with childhood growth hormone deficiency
This study follows adults who had growth hormone deficiency as children and are now part of a research registry. It aims to understand their health outcomes as they transition into adulthood.
Brussels, Woluwe-saint-lambertAges 18 years+ - NCT03972345Enrolling by invitation
Study on how sticking to growth hormone affects near adult height
This study looks at whether consistently taking growth hormone (Norditropin) helps children reach a height goal by “near final height.” It focuses on children who are short due to growth hormone deficiency or born small for gestational age.
UlmAges birth–15 years - NCT07264595RecruitingPhase 1/Phase 2
Study of GS3-007a for children with growth hormone deficiency
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
Wuhan, HubeiAges 3 years+ - NCT07795736Recruiting
Understanding growth hormone problems after brain injury
This study looks at how a traumatic brain injury might affect your body's growth hormone, which is important for energy, strength, and overall health. If you've had a brain injury and still have symptoms a year later, you may be able to help researchers learn more and possibly find better treatments.
Calgary, AlbertaAges 18–70 - NCT06803589RecruitingEarly Phase 1
Growth hormone for hard-to-treat stomach paralysis
This study tests if growth hormone can help people with long-term stomach paralysis (gastroparesis) that hasn't improved with standard care. It looks at whether the treatment reduces symptoms like nausea and feeling full too quickly.
Phoenix, ArizonaAges 18–65 - NCT05746650Recruiting
Study to improve healing after knee muscle-tendon repair
This study looks at how to improve healing at the muscle-tendon connection after knee reconstruction surgery. You may be able to join if you’re otherwise healthy, within a certain body-size range, and not using medicines that could change muscle or tendon healing.
CopenhagenAges 18–35 - NCT06109935Enrolling by invitation
Long-term study of Sogroya for children with growth hormone deficiency
This trial is looking at how well Sogroya® (a growth hormone medicine) works when used for a long time in children with short stature caused by growth hormone deficiency. The goal is to see if it helps them grow taller safely.
AichiAges birth–18 years - NCT01604395Recruiting
Long-term growth hormone check for children with short stature
This study follows children who are short for their age and checks how safe and effective growth hormone is over the long term. It may help families understand expected benefits and side effects for their specific growth-related condition.
SeoulAges 2 years+ - NCT05796440Enrolling by invitationPhase 2
Long-term safety study of LUM-201 in children with growth hormone deficiency
This trial checks the long-term safety of LUM-201 in children who have idiopathic growth hormone deficiency and already completed an earlier LUM-201 study. If you previously took LUM-201 and are allowed to continue, the study may help your care team monitor ongoing effects over time.
Iowa City, IowaAges 5–14 - NCT05718570Enrolling by invitation
Long-term follow-up for adults taking Sogroya for growth hormone deficiency
This study follows adults with growth hormone deficiency who start (or have started) Sogroya to learn about its long-term safety. It does not change your treatment—it mainly checks for side effects and health outcomes over time.
Phoenix, ArizonaAges 18 years+ - NCT06709040Enrolling by invitation
Long-term safety of somapacitan in children with growth hormone deficiency
This study is watching children who are already taking somapacitan (a growth hormone injection) to see if it is safe over a long time. It collects information about growth and any side effects.
Glasgow, ScotlandAges Up to 18 years
What Growth Hormone is being studied for
Conditions with recruiting Growth Hormone studies.
Common questions
- Are there clinical trials studying Growth Hormone?
- Yes. Clin2 currently lists 53 recruiting studies that include Growth Hormone, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Growth Hormone trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Growth Hormone an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Growth Hormone or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.